
276 episodes

Cytokine Signalling Forum Cytokine Signalling Forum
-
- Education
-
-
5.0 • 8 Ratings
-
Keeping you up to date with the latest in rheumatology and cytokine signalling
-
AxSpA Podcast: Safety and Efficacy of Tofacitinib and Bimekizumab
Join Doctor Sofia Ramiro as she is joined by Professors Atul Deodhar and Xenofon Baraliakos to discuss the latest top clinical research in the world of axSpA. In the first paper discussed, the authors evaluated the efficacy and safety of tofacitinib in bDMARD-naïve and TNF-IR AS patients. The second paper presents the results of two parallel clinical trials that investigated the safety and efficacy of bimekizumab.
-
PsA Podcast: Gender differences in treating PsA & safety of guselkumab in treating PsO and PsA
Join Peter Nash, Professor at the School of Medicine, Griffith University, and Director of the Rheumatology Research Unit on the Sunshine Coast, Australia, Philip Mease, Professor at the University of Washington School of Medicine, and Director of Rheumatology Research at the Swedish Medical Centre in Seattle, USA, as well as Laura Coates, an Associate Professor, NIHR clinician scientist and senior clinical research fellow at the Oxford Psoriatic Arthritis Centre as they discuss two intriguing aspects of the contemporary PsA treatment landscape. The first of the publications relates to the effects of gender on disease characteristics, treatment impact and treatment persistence. The second publication explores the long-term safety profile of guselkumab in the treatment of PsO and PsA.
-
Discussing Rheumatology: November 2023
Join Professor Iain McInnes in this month's CSF Podcast, where he discusses the latest information and data in rheumatology.
In this episode, he discusses two papers that look at the incidence of disease. The first paper, the GBD 2021 Other Musculoskeletal Disorders Collaborators systematically analysed the global burden of musculoskeletal disorders, and used these data to predict prevalence up to 2050 and the second paper, Yvette Meissner and her colleagues used the German RABBIT registry to investigate the relationship between MACE risk and JAK inhibitors, TNF inhibitors, and DMARDs.
To access detailed summary slides for the papers discussed today, visit cytokinesignalling.com. -
ACR 2023 Highlights: Day 4
Join Sofia Ramiro as she goes through our top abstracts, posters, and presentations from Day 4 of ACR 2023 today (Wednesday 15 November).
They're all available right here on the CSF YouTube channel, so make sure you don't miss them! -
ACR 2023 Highlights: Day 3
Join Grace Wright as she goes through our top abstracts, posters, and presentations from Day 3 of ACR 2023 today (Tuesday 14 November).
They're all available right here on the CSF YouTube channel, so make sure you don't miss them! -
ACR 2023 Highlights: Day 2
Join Laura Coates as she goes through our top abstracts, posters, and presentations from Day 2 of ACR 2023 today (Monday 13 November).
They're all available right here on the CSF YouTube channel, so make sure you don't miss them!